Lunit Inc.
328130
Rank in Stocks
#11524
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea,... Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Share Price
$8.73
Market Cap
$649.63M
Change (1 day)
-2.32%
Change (1 year)
1,046.78%
Country
KR
Trade Lunit Inc. (328130)
Category
Healthcare
P/S ratio for Lunit Inc. (328130)
P/S ratio as of 2026 TTM: 0
According to Lunit Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Lunit Inc. from 2026 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 1.53 | - |
US
|
|
| 65.30 | - |
AU
|
|
| 0.87 | - |
US
|
|
| 8.37 | - |
US
|
|
| 15.04 | - |
US
|
